ZINFORT
Commercial- Indications
- Immune support
Company intelligence / Profile preview
OMNIFARMA
Ukraineomnifarma-europe.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Ukraine-based producer since2008 with16 brands, operating in14+ countries through GMP-certified manufacturing and clinically tested supplements[1].
- Therapeutic areas
- Other
- Modalities
- Small molecules(Presumably) Nutraceuticals(Presumably) Herbal formulations
- Industry
- Food & Nutrition
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
{"type":"Founding partnership","description":"Ukraine-Germany professional collaboration since2008[1]"}
Beyond the preview
Go deeper on OMNIFARMA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OMNIFARMA.